Article citationsMore>>

Topol, E.J. (2004) Failing the Public Health—Rofecoxib, Merck, and the FDA. The New England Journal of Medicine, 351, 1707-1709.
https://doi.org/10.1056/NEJMp048286

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top